Cross-Study Review of the Clinical Efficacy of Apomorphine SL 2 and 3 mg: - Pooled Data from Three Placebo-Controlled, Fixed-Dose Crossover Studies

By Stief C.   Padley R.J.   Perdok R.J.   Sleep D.J.  

European Urology Supplements, Vol. 1, Iss. 3, 2002-05 ,pp. : 12-20

Elsevier

Access to resources Recommend Favorite

Safety and Tolerability of Apomorphine SL in Men with Cardiovascular Disorders

By Adams M.A.   Perdok R.J.   Padley R.J.   Sleep D.J.  

European Urology Supplements, Vol. 1, Iss. 3, 2002-05 ,pp. : 28-32

Elsevier

Access to resources Recommend Favorite

National Analysis of Adverse Patient Safety Events in Bariatric Surgery

By Poulose Benjamin K   Griffin Marie R   Yuwei Zhu   Walter Smalley   Richards William O   Wright J. Kelly   Willie Melvin   Holzman Michael D  

The American Surgeon, Vol. 71, Iss. 5, 2005-05 ,pp. : 406-413

Southeastern Surgical Congress

Access to resources Recommend Favorite

The Role of Apomorphine SL in the Treatment of Erectile Dysfunction

By Montorsi F.  

European Urology Supplements, Vol. 1, Iss. 3, 2002-05 ,pp. : 4-11

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of daily intake of apomorphine SL in men affected by erectile dysfunction and mild hyperprolactinemia: a prospective, open-label, pilot study

By Caruso S.   Intelisano G.   Farina M.   DiMari L.   Agnello C.   Giammusso B.  

Urology, Vol. 62, Iss. 5, 2003-11 ,pp. : 922-927

Elsevier

Access to resources Recommend Favorite